Invesco: China's health sector measures up to the world's best

Robust income growth and an aging population are driving the rapid development and growth of the world's second largest health industry. From the development of vaccines to innovative pharmaceuticals and biotechnology, China's health industry is increasingly among the world's top performers. We spoke to Chris Liu, senior portfolio manager Asia Pacific at Invesco Management, about the opportunities the Chinese healthcare industry offers investors. 

Investment Officer is an editorially independent media platform in the Benelux countries providing industry news and insights to investment professionals working for asset owners, asset managers and asset servicing companies.

The Netherlands: http://www.investmentofficer.nl
Belgium: http://www.investmentofficer.be
Luxembourg: http://www.investmentofficer.lu